[1]
He, Y. et al. 2025. Exploring New Therapeutic Targets for Myasthenia Gravis: A Plasma and Cerebrospinal Fluid Proteomics Mendelian Randomization Study. Life Conflux. 2, 1 (Oct. 2025), e249. DOI:https://doi.org/10.71321/ybarkw62.